You are here

Point of Care Test for Disease Severity and Risk Stratification

Award Information
Agency: Department of Defense
Branch: Defense Health Program
Contract: W81XWH19C0012
Agency Tracking Number: H2-0383
Amount: $989,127.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: DHA172-008
Solicitation Number: 2017.2
Timeline
Solicitation Year: 2017
Award Year: 2019
Award Start Date (Proposal Award Date): 2019-03-01
Award End Date (Contract End Date): 2021-07-31
Small Business Information
2501 Earl Rudder Freeway South, College Station, TX, 77845
DUNS: 184758308
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Dr. Kelley Reaves
 (979) 764-2200
 kelley.reaves@lynntech.com
Business Contact
 Mrs. Taylor Blincoe
Phone: (979) 764-2200
Email: contract@lynntech.com
Research Institution
N/A
Abstract
Lynntech will design and build a prototype scale reduced weight, environmentally stable, CBC device which is usable at Roles 2 and higher which requires no cold chain storage. The device is specifically intended to be used by medical personnel deployed in Health Response Teams (HRTs) who are not lab technicians and who do not have rapid, reliable access to a hematology lab. To this end, the solution cannot add significantly to their labor while increasing their diagnostic capacity in pre-hospital care. Lynntech will use state of the art microfluidic disposable cartridges and a micronized reader unit, capable of five-part differentiation of WBCs as well as the usual RBC and platelet statistical measures, be self-calibrating, and support storage, recall, and reporting for more than one hundred patients results in a HIPAA compliant way. Lynntech will use its internal team with experience in related development efforts as well as outside subject matter experts and their microfabrication facilities.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government